Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

1.2K
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.2K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

409
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

1.8K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.8K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

559
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

549
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
549
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

P2X4 receptors on myeloid cells mediate tissue injury in a model of trauma and hemorrhagic shock in male mice.

Purinergic signalling·2026
Same author

P2X4 receptors on myeloid cells mediate tissue injury in a murine model of trauma and hemorrhagic shock.

Research square·2025
Same author

The perioperative care in liver transplantation multicenter database: Building the foundation for research collaboration in liver transplantation.

Journal of clinical anesthesia·2024
Same author

Regional anesthesia for transplantation surgery - A White Paper Part 2: Abdominal transplantation surgery.

Clinical transplantation·2024
Same author

Regional anesthesia for transplantation surgery - A white paper part 1: Thoracic transplantation surgery.

Clinical transplantation·2023
Same author

Multi‑faceted roles of cathepsins in ischemia reperfusion injury (Review).

Molecular medicine reports·2022

Related Experiment Video

Updated: May 3, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.6K

Updates on Hepato-Renal Syndrome.

Kyota Fukazawa1, H Thomas Lee1

  • 1Department of Anesthesiology, College of Physicians and Surgeons of Columbia University, NY, USA.

Journal of Anesthesia & Clinical Research
|January 25, 2014
PubMed
Summary

Hepato-renal syndrome (HRS) is a severe complication of end-stage liver failure. This review covers recent advances in understanding and managing HRS, aiming for improved patient outcomes.

Area of Science:

  • Hepatology
  • Nephrology
  • Internal Medicine

Background:

  • Hepato-renal syndrome (HRS) is a critical complication in end-stage liver disease.
  • Historically viewed as terminal, HRS presents significant management challenges.
  • Type 1 HRS, in particular, is associated with extremely high mortality rates.

Purpose of the Study:

  • To review recent advancements in the pathophysiology of Hepato-renal syndrome (HRS).
  • To summarize current diagnostic criteria and management strategies for HRS.
  • To highlight emerging research areas in HRS pathophysiology for novel therapeutic development.

Main Methods:

  • Literature review of recent studies on Hepato-renal syndrome (HRS).
  • Synthesis of current understanding of HRS pathophysiology.
Keywords:
Acute kidney injuryCirrhosisEndothelial cellInflammation

More Related Videos

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

7.9K
Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection
06:00

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection

Published on: December 30, 2025

615

Related Experiment Videos

Last Updated: May 3, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.6K
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

7.9K
Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection
06:00

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection

Published on: December 30, 2025

615
  • Analysis of established and evolving diagnostic and management approaches.

    • Main Results:

    • Despite improved understanding, mortality for Hepato-renal syndrome (HRS), especially type 1, remains high.
    • Renal dysfunction in HRS is recognized as potentially reversible.
    • Advances in pathophysiology offer potential for new therapeutic targets.

    Conclusions:

    • Hepato-renal syndrome (HRS) requires continued research into its complex pathophysiology.
    • Effective management of HRS necessitates a multidisciplinary approach.
    • Emerging research holds promise for developing novel treatments to improve HRS patient survival.